| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |